How did BAYRY's recent EPS compare to expectations?
The most recent EPS for Bayer Aktiengesellschaft is $0.62, beating expectations of $0.5.
How did Bayer Aktiengesellschaft BAYRY's revenue perform in the last quarter?
Bayer Aktiengesellschaft revenue for the last quarter is $0.62
What is the revenue estimate for Bayer Aktiengesellschaft?
According to 5 of Wall street analyst, the revenue estimate of Bayer Aktiengesellschaft range from $11.53B to $10.22B
What's the earning quality score for Bayer Aktiengesellschaft?
Bayer Aktiengesellschaft has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Bayer Aktiengesellschaft report earnings?
Bayer Aktiengesellschaft next earnings report is expected in 2026-06-02
What are Bayer Aktiengesellschaft's expected earnings?
Bayer Aktiengesellschaft expected earnings is $11.36B, according to wall-street analysts.
Did Bayer Aktiengesellschaft beat earnings expectations?
Bayer Aktiengesellschaft recent earnings of $11.43B beat expectations.
Key Stats
Prev.Close
$10.87
Open
$10.98
Day's Range
$10.78 - $10.99
52 week range
$6.2 - $14.85
Volume
148.0K
Avg.Volume
1.2M
Dividend yield
--
EPS (TTM)
-1.08
Market Cap
$42.6B
What is Bayer A.G.?
Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 92,815 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.